This bid is closed — responses were due September 3, 2026.
It is no longer accepting submissions. We keep closed bids on BidsNexus for reference: agencies often re-issue the same need, and past bids show what they buy and when.
This bid is for assay services to evaluate the ADME and in vivo PK properties of new molecular entities developed by the Section on Medicinal Chemistry.